search

1-20 of 31

Save search

Sort by

Sort Order Select

Journal Article

EXTH-41. COMBINATION TREATMENT WITH RAF/MEK AND FAK INHIBITION ENHANCES TUMOR GROWTH INHIBITION IN MENINGIOMA

PDF

Nazanin Ijad and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii246, https://doi.org/10.1093/neuonc/noae165.0972

Published: 11 November 2024

Journal Article

DDDR-04. PRECLINICAL INVESTIGATION OF A NOVEL BRAIN PENETRANT COMBINATION THERAPY TARGETING RAF AND MEK FOR MELANOMA BRAIN METASTASIS

PDF

Erika Yamazawa and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii126, https://doi.org/10.1093/neuonc/noae165.0489

Published: 11 November 2024

Journal Article

CSIG-12. YAP1-TEAD SIGNALING CONTRIBUTES TO LUNG CANCER COLONIZATION OF THE BRAIN

PDF

Consuelo Torrini and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii66, https://doi.org/10.1093/neuonc/noae165.0261

Published: 11 November 2024

Journal Article

The ERK inhibitor LY3214996 augments anti-PD-1 immunotherapy in preclinical mouse models of BRAF^V600E melanoma brain metastasis

PDF

Magali A de Sauvage and others

Neuro-Oncology, Volume 26, Issue 5, May 2024, Pages 889–901, https://doi.org/10.1093/neuonc/noad248

Published: 22 December 2023

Supplementary data

Journal Article

DDDR-32. EVALUATING THE THERAPEUTIC EFFECTS OF SMALL MOLECULE INHIBITORS OF CDK4/6 AND FAK IN PRECLINICAL MENINGIOMA MODELS

PDF

Nazanin Ijad and others

Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v112–v113, https://doi.org/10.1093/neuonc/noad179.0425

Published: 10 November 2023

Journal Article

EXTH-45. DEVELOPMENT OF COMBINATION THERAPIES OF KRAS^G12C INHIBITOR ADAGRASIB IN PRECLINICAL MODELS OF BRAIN METASTASIS

PDF

Consuelo Torrini and others

Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v234, https://doi.org/10.1093/neuonc/noad179.0898

Published: 10 November 2023

Journal Article

EXTH-42. PRECLINICAL INVESTIGATION OF A NOVEL BRAIN PENETRANT MEK INHIBITOR TO TARGET BRAIN METASTASIS

PDF

Erika Yamazawa and others

Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v233–v234, https://doi.org/10.1093/neuonc/noad179.0895

Published: 10 November 2023

Journal Article

NIMG-76. A DEEP LEARNING ALGORITHM FOR FULLY AUTOMATED VOLUMETRIC MEASUREMENT OF MENINGIOMA BURDEN

PDF

Mason Cleveland and others

Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v203, https://doi.org/10.1093/neuonc/noad179.0771

Published: 10 November 2023

Journal Article

DDDR-05. ERK INHIBITION INCREASES SENSITIVITY TO ANTI-PD-1 THERAPY IN A MOUSE MODEL OF BRAF MUTANT MELANOMA BRAIN METASTASIS

PDF

Magali de Sauvage and others

Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii99, https://doi.org/10.1093/neuonc/noac209.370

Published: 14 November 2022

Journal Article

DDDR-02. CDK4/6 INHIBITION WITH ABEMACICLIB SENSITIZES INTRACRANIAL TUMORS TO CHECKPOINT BLOCKADE IN PRE-CLINICAL MODELS OF BRAIN METASTASIS

PDF

Naema Nayyar and others

Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii98, https://doi.org/10.1093/neuonc/noac209.367

Published: 14 November 2022

Journal Article

EXTH-89. EXPLORING ANTI-TUMOR EFFECTS OF SMALL MOLECULE INHIBITORS OF CDK4/6, FAK, AND RAF/MEK IN PRECLINICAL MODELS OF MENINGIOMA

PDF

Nazanin Ijad and others

Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii230, https://doi.org/10.1093/neuonc/noac209.887

Published: 14 November 2022

Journal Article

CTIM-30. PHASE II TRIAL OF PEMBROLIZUMAB IN RECURRENT AND RESIDUAL HIGH-GRADE MENINGIOMAS

PDF

Priscilla Brastianos and others

Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi57, https://doi.org/10.1093/neuonc/noab196.222